E. Maciá et al. / Tetrahedron: Asymmetry xxx (2017) xxx–xxx
5
4.3.4. (SS,E)-N-(tert-Butanesulfinyl)-2-imino-1-(4-methoxyphenyl)-
ethan-1-one 3d
(C), 119.7 (CH2), 131.9 (CH), 172.6 (CH); LRMS (EI) m/z 161
(M+ꢀ56, 15%), 146 (60), 120 (100), 91 (13), 57 (50); HRMS calcd
for C10H19NO2S: 217.1136; found: 217.1136.
The representative procedure was followed by using
hemithioketal 6d (1.06 g, 5.0 mmol). Purification by column chro-
matography (hexane/AcOEt, 4:1) yielded 3d (0.921 g, 3.45 mmol,
69%) as a yellow solid, mp 64–65 °C (hexane/CH2Cl2); Rf 0.60 (hex-
4.4.3. (SS,4S,5R)-5-Amino-N-(tert-butanesulfinyl)-4-methylocta-
1,7-dien-4-ol 10a
The representative procedure was followed by using a-keto
imine 3a (0.0875 g, 0.5 mmol). Purification by column chromatog-
ane/EtOAc, 2:1); [
a
]
D
30 = +48.7 (c 1.00, CH2Cl2); IR (neat)
m
2939,
1666, 1590, 1509, 1309, 1261, 1251, 1167, 1022 cm–1
;
1H NMR
(300 MHz, CDCl3) d 1.29 [9H, s, (CH3)3], 3.90 (3H, s, CH3), 6.99 (2H,
d, J = 9.0 Hz, 2 ꢁ CH), 8.16 (2H, d, J = 9.0 Hz, 2 ꢁ CH); 8.48 (1H, s,
CH); 13C NMR (100 MHz, CDCl3) 22.7 (CH3), 55.6 (CH3), 58.5 (C),
114.1 (CH), 127.6 (C), 131.5 (C), 132.6 (CH), 161.3 (CH), 186.4 (C);
LRMS (EI) m/z 161 (M+ꢀ106, 60%), 135 (100), 77 (15); HRMS calcd
for C9H7NO2 (M+ꢀC4H10SO): 161.0477; found: 161.0478.
raphy (hexane/AcOEt, 4:1) yielded 10a (0.032 g, 0.125 mmol, 25%)
as a yellow oil; Rf 0.21 (hexane/EtOAc, 2:1); [
CH2Cl2); IR (neat) 2892, 1652, 1614, 1475, 1402, 1274, 1167,
1095 cm–1 1H NMR (300 MHz, CDCl3) d 1.24 [9H, s, (CH3)3], 1.26
a]
30 = +18.1 (c 1.00,
D
m
;
(3H, s, CH3), 2.10–2.55 (4H, m, 2 ꢁ CH2), 3.21 (1H, dt, J = 10.5,
3.0 Hz, CH), 3.82 (1H, d, J = 5.1 Hz, NH), 4.01 (1H, br s, OH), 5.02–
5.31 (4H, m, 2 ꢁ CH2), 5.81–6.10 (2H, m, 2 ꢁ CH); 13C NMR
(100 MHz, CDCl3) d 22.9 (CH3), 26.1 (CH3), 37.1 (CH2), 42.1 (CH2),
56.4 (C), 68.0 (CH), 73.3 (C), 117.1 (CH2), 117.9 (CH2), 135.1 (CH),
135.7 (CH); LRMS (EI) m/z 203 (M+ꢀ56, 18%), 191 (9), 163 (100),
157 (50), 146 (95), 130 (97), 117 (41), 109 (18), 89 (92), 55 (37);
HRMS calcd for C9H17NO2S (M+ꢀC4H8): 203.0980; found: 203.0988.
4.3.5. (SS,E)-N-(tert-Butanesulfinyl)-1-iminoundecan-2-one 3e
The representative procedure was followed by using
hemithioketal 6e (1.16 g, 5.0 mmol). Purification by column chro-
matography (hexane/AcOEt, 4:1) yielded 3e (0.79 g, 2.75 mmol,
55%) as a yellow oil; Rf 0.94 (hexane/EtOAc, 2:1); [
(c 1.12, CH2Cl2); IR (neat) 2954, 2923, 2854, 1702, 1458, 1365,
a]
30 = +176.2
D
m
1094 cm–1; 1H NMR (300 MHz, CDCl3) d 0.88 (3H, t, J = 6.3 Hz, CH2-
CH3), 1.24–1.31 [21H, m, 6 ꢁ CH2 and (CH3)3], 1.66 (2H, m, CH2),
2.86 (2H, t, J = 7.5 Hz, CH2), 7.93 (1H, s, CH); 13C NMR (100 MHz,
CDCl3) d 14.8 (CH3), 22.6 (CH3), 22.8 (CH2), 23.5 (CH2), 29.1
(CH2), 29.2 (CH2), 29.3 (CH2), 29.4 (CH2), 31.8 (CH2), 38.0 (CH2),
58.6 (C), 160.5 (CH), 198.2 (C); LRMS (EI) m/z 181 (M+ꢀ106, 5%),
152 (19), 124 (56), 98 (90), 55 (100); HRMS calcd for C11H19NO (M-
4.4.4. (SS,4S⁄,5R)-5-Amino-N-(tert-butanesulfinyl)-4-pheny-
locta-1,7-dien-4-ol 10b
The representative procedure was followed by using
a-keto
imine 3b (0.120 g, 0.5 mmol). Purification by column chromatogra-
phy (hexane/AcOEt, 4:1) yielded 10b (0.042 g, 0.13 mmol, 26%) as a
yellow oil (58:42 mixture of diastereoisomers); Rf 0.34 (hexane/
EtOAc, 2:1); IR (neat)
m 2902, 1475, 1450, 1326, 1274, 1167,
1095 cm–1 1H NMR (300 MHz, CDCl3) d 1.18 and 1.21 [9H, 2 s,
;
+
ꢀC4H10SO): 181.1467; found: 181.1469.
(CH3)3], 1.84–1.90 (2H, m, CH2), 2.41–2.48 (2H, m, CH2), 2.83
(1H, d, J = 6.9 Hz, NH), 3.41–3.46 (1H, m, CH), 3.77 and 4.79 (1H,
2 br s, OH), 4.91–5.30 (4H, m, 2 ꢁ CH2), 5.50–5.86 (2H, m,
2 ꢁ CH), 7.30–7.53 (5H, m, 5 ꢁ CH); 13C NMR (100 MHz, CDCl3) d
22.8 (CH3), 22.9 (CH3), 36.0 (CH2), 37.0 (CH2), 41.2 (CH2), 43.4
(CH2), 56.6 (C), 56.7 (C), 66.3 (CH), 67.1 (CH), 77.0 (C), 77.4 (C),
117.1 (CH2), 117.2 (CH2), 118.6 (CH2), 119.3 (CH2), 126.7 (CH),
126.8 (CH), 127.2 (CH), 127.3 (CH), 128.1 (CH), 128.2 (CH), 133.5
(CH), 134.3 (CH), 135.4 (CH), 135.7 (CH), 142.2 (C), 142.9 (C); LRMS
(EI) m/z 265 (M+ꢀ56, 10%), 224 (19), 183 (100), 147 (50), 77 (24),
55 (47); HRMS calcd for C10H20NOS (M+ꢀC8H7O): 202.1266; found:
202.1259.
4.4. General procedure for the allylation of N-tert-
butanesulfinyl-
a
-keto aldimines 3. Synthesis of compounds 10
To a solution of the corresponding
a-keto imine 3 (0.5 mmol) in
THF (2 mL) was added the corresponding allylic bromide 4
(0.225 g, 0.161 mL, 1.5 mmol) and indium (0.143 g, 1.25 mmol).
The resulting suspension was stirred at 23 °C for 6 h and after that
quenched with brine (4.0 mL) and extracted with ethyl acetate
(3 ꢁ 10 mL). The organic layer was dried over anhydrous magne-
sium sulfate and evaporated (15 Torr). The resulting residue was
then purified by column chromatography (silica gel, hexane/ethyl
acetate) to yield pure compounds 10. Yields, physical and spectro-
scopic data for these compounds follow.
4.4.5. (SS,4R,5S)-5-Allyl-4-amino-N-(tert-butanesulfinyl)tetra-
dec-1-en-5-ol 10e
4.4.1. (SS,3R)-3-Amino-N-(tert-butanesulfinyl)hex-5-en-2-one
The representative procedure was followed by using a-keto
8a
imine 3e (0,143 g, 0.5 mmol). Purification by column chromatogra-
Yellow oil; RF 0.17 (hexane/AcOEt 2:1); [
CH2Cl2); IR (neat) 2950, 1713, 1639, 1457, 1386, 1364, 1041,
910 cm–1 1H NMR (300 MHz, CDCl3) d 1.26 [9H, s, (CH3)3], 2.25
(3H, s, CH3), 2.43–2.65 (2H, m, CH2), 4.14 (H, q, J = 5.0 Hz, CH),
4.56 (H, d, J = 5.0 Hz, NH), 5.10–5.16 (2H, m, CH2), 5.62–5.74 (1H,
m, CH); 13C NMR (100 MHz, CDCl3) d 22.7 (CH3), 27.2 (CH3), 37.2
(CH2), 56.0 (C), 62.5 (CH), 118.85 (CH2), 132.1 (CH), 205.9 (C);
LRMS (EI) m/z 174 (M+ꢀ43, 18%), 161 (28), 146 (13), 118 (100),
91 (24), 57 (37); HRMS calcd for C8H16NOS (M+ꢀC2H3O):
174.0953; found: 174.0953.
a]
30 = +20.3 (c 0.65,
D
phy (hexane/AcOEt, 4:1) yielded 10e (0.068 g, 0.185 mmol, 37%) as
m
a yellow oil; Rf 0.34 (hexane/EtOAc, 2:1); [
Cl2); IR (neat) 2920, 2903, 2865, 1665, 1644, 1252, 1235, 1083,
975 cm–1 1H NMR (300 MHz, CDCl3) d 0.88 (3H, t, J = 5.1 Hz,
a]
30 = +56.1 (c 1.12, CH2-
D
;
m
;
CH3), 1.24 [9H, s, (CH3)3], 1.26–1.34 (16H, m, 8 ꢁ CH2), 2.04–2.39
(4H, m, 2 ꢁ CH2), 3.29 (1H, td, J = 7.8, 1.8 Hz, CH), 3.88 (1H, d,
J = 1.8 Hz, NH), 5.04–5.15 (4H, m, 2 ꢁ CH2), 5.71–5.83 (1H, m,
CH), 5.99–6.12 (1H, m, CH); 13C NMR (100 MHz, CDCl3) d 14.1
(CH3), 22.6 (CH2), 22.7 (CH2), 22.9 (CH3), 29.3 (CH2), 29.5 (CH2),
29.6 (CH2), 30.2 (CH2), 31.9 (CH2), 37.1 (CH2), 38.9 (CH2), 41.8
(CH2), 56.3 (C), 66.1 (CH), 74.5 (C), 117.0 (CH2), 117.5 (CH2),
135.7 (CH), 136.1 (CH); LRMS (EI) m/z 315 (M+ꢀ56, 14%), 274
(35), 233 (28), 141 (60), 113 (100), 85 (60) 71 (55), 57 (47); HRMS
calcd for C17H33NO2S (M+ꢀC4H8): 315.2232; found: 315.2238.
4.4.2. (SS)-N-(tert-Butanesulfinyl)-1-imino-2-methylpent-4-en-
2-ol 9a
Yellow oil (diastereomeric mixture); RF 0.45 (hexane/AcOEt
2:1); IR (neat)
m ;
2970, 1683, 1452, 1312, 1201, 1049, 896 cm–1
1H NMR (300 MHz, CDCl3) d 1.21 and 1.22 [9H, 2s, (CH3)3], 1.37
and 1.39 (3H, 2s, CH3), 2.44–2.48 (2H, m, CH2), 3.31 (1H, br s,
OH), 5.10–5.20 (2H, m, CH2), 5.51–5.92 (1H, m, CH), 8.06 (1H, s,
CH); 13C NMR (100 MHz, CDCl3) d 14.1 (CH3) 21.8 (CH3), 22.7
(CH3), 23.1 (CH3), 44.5 (CH2), 44.6 (CH2), 56.8 (C), 74.9 (C), 75.1
4.5. General procedure for the ring-closing metathesis of
compounds 10. Synthesis of aminocyclohexenols 11
A mixture of the corresponding 1,7-octadiene 10 (0.25 mmol),
ruthenium Hoveyda–Grubbs catalyst (7 mg, 0.0225 mmol) in dry